1. Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?
   Julia S. Johansen et al, 2006, Cancer Epidemiology, Biomarkers & Prevention CrossRef
2. Prognostic and predictive role of YKL-40 in anal squamous cell carcinoma: a serological and tissue-based analysis in a multicentric cohort
   Alessandro Gambella et al, 2024, Frontiers in Medicine CrossRef
3. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway
   Julia Kzhyshkowska et al, 2006, Blood CrossRef
4. Serum YKL-40 Predicts Relapse-Free and Overall Survival in Patients With American Joint Committee on Cancer Stage I and II Melanoma
   Henrik Schmidt et al, 2006, Journal of Clinical Oncology CrossRef
5. Diurnal, Weekly, and Long-Time Variation in Serum Concentrations of YKL-40 in Healthy Subjects
   Julia S. Johansen et al, 2008, Cancer Epidemiology, Biomarkers & Prevention CrossRef
6. YKL-40 Expression is Associated with Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma
   Christopher E. Pelloski et al, 2005, Clinical Cancer Research CrossRef
7. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival
   Shan Xing et al, 2017, World Journal of Gastroenterology CrossRef
8. High Serum Concentration of YKL-40 Is Associated with Short Survival in Patients with Acute Myeloid Leukemia
   Olav J. Bergmann et al, 2005, Clinical Cancer Research CrossRef
9. Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma
   Janice M. Nigro et al, 2005, Cancer Research CrossRef